Back to the 'essence' of medical treatment in oncology: the 2015 WHO Model List of Essential Medicines
- PMID: 27843592
- PMCID: PMC5070297
- DOI: 10.1136/esmoopen-2015-000030
Back to the 'essence' of medical treatment in oncology: the 2015 WHO Model List of Essential Medicines
Keywords: WHO; essential medicines.
Conflict of interest statement
Conflicts of Interest: None declared.
Figures
References
-
- 2015 WHO Model List of Essential Medicines. http://www.who.int/medicines/publications/essentialmedicines/en/
-
- Cherny NI, Baselga J, de Conno F et al. Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in Europe: a report from the ESMO/EAPC Opioid Policy Initiative. Ann Oncol 2010;21:615–26. doi:10.1093/annonc/mdp581 - DOI - PubMed
-
- Cherny NI, Cleary J, Scholten W et al. The Global Opioid Policy Initiative (GOPI) project to evaluate the availability and accessibility of opioids for the management of cancer pain in Africa, Asia, Latin America and the Caribbean, and the Middle East: introduction and methodology. Ann Oncol 2013; 24(Suppl 11):xi7–13. doi:10.1093/annonc/mdt498 - DOI - PubMed
-
- ESMO European Consortium Study on the availability, out-of-pocket costs and accessibility of anti-neoplastic medicines. Nathan I Cherny, Richard Sullivan, Julie Torode, Marika Saar, Alexandru Eniu. To be published in Annals of Oncology in 2016. http://www.esmo.org/Policy/Anti-Cancer-Medicines-Availability/European-S... - PubMed
-
- ESMO International Consortium Study on the availability, out-of-pocket costs and accessibility of anti-neoplastic medicines. Nathan I Cherny, Richard Sullivan, Julie Torode, Marika Saar, Alexandru Eniu. To be published by ESMO in 2016. http://www.esmo.org/Policy/Anti-Cancer-Medicines-Availability/Internatio...
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
